NIPT involves a simple blood draw from the pregnant woman, usually after the 10th week of pregnancy. The sample is then analyzed in a laboratory to detect anomalies in the fetal DNA. This method is non-invasive because it does not require any direct sampling from the fetus, such as amniocentesis or chorionic villus sampling (CVS).
